Navigation Links
Swelling of Prostate Gland Prevented with New drug

Estrogen regulating drugs might aid in prevention of enlargement of the prostate gland in older men according to Australian scientists. //

Results of animal studies that were presented at a medical conference in London showed that an experimental estrogen-regulating drug prevented the swelling of the prostate gland which occurs as men age.

Professor Gail Risbridger, of Monash University in Melbourne said, “We still have to try the drugs in humans, but so far these are very promising results.”

“This work holds out the possibility that we may be able to help patients with benign disease as well as men with prostate cancer by using these designer drugs.”

Enlarged prostate, or benign prostate hyperplasia (BPH) is a common disease in men over 60 causing urinary problems, infections and pain.

Although estrogen is generally considered a female hormone it also plays a role in the development of the prostate gland having both positive and negative effects.

Risbridger said, “There are two things that estrogens do, good and bad, but in different diseases.”

The bad effect is that the hormone can cause malignancy but on the positive side it can stop BPH from developing.

On testing an estrogen receptor-beta agonist on transgenic mice with BPH Risbridger and her team found that the drug activated just one of the two cell receptors for the hormone to produce the positive impact. This was presented at the Society for Endocrinology conference.

The scientists found that regulating the estrogen receptor beta stopped the development of benign prostate hyperplasia, while the negative effects were due to switching on the estrogen receptor alpha.

She said, “When you give one of the estrogen selective drugs that only activates a particular type of estrogen receptor, beta, you can prevent the hyperplasia from developing.”

The drug was found to stop the development of the illness and improve the health of the animals which had existing BPH.

Risbridger added, “Ideally, we would want to promote the good effects of estrogen receptor beta and block the bad effects of estrogen receptor alpha.”

“It’s interesting work, and we are pleased that preclinical testing may translate into real benefits for patients.”

Source-Medndia
NLA
'"/>




Related medicine news :

1. Swelling increases stroke risk with high B.P.
2. Do Not Neglect Your Abdominal Pain/ Swelling - Help Your Doctor In Early Cancer Detection
3. Brain Swelling Key to Reducing Stroke Fatalities
4. Surgeon Develops Procedure to Prevent Arm Swelling in Breast Cancer Patients
5. Cancer Doctors Okays Controversial Prostate Therapy
6. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
7. New Prostate Cancer Vaccine Shows Promise
8. Hormone Therapy applicable for Prostate Cancer
9. Prostate cancer and Vitamins
10. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
11. Early Detection Of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... San Rafael, CA (PRWEB) , ... May 26, ... ... Studio will be offering campers a multitude of activities from daily practices, arts ... and self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds ...
(Date:5/26/2016)... ... ... The MIAMI Institute for Age Management and Intervention celebrates Global Wellness Day with ... Adonis , Wellness Physician of the MIAMI Institute is certified by the American Academy ... , He also heads up FITTLab, the comprehensive medical testing lab located in The ...
(Date:5/26/2016)... ... 26, 2016 , ... Power Systems, a leading developer and ... Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ Education ... hour interactive course to qualify participants as certified PowerWave trainers. , PowerWave ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... information to oncology professionals, has added National Cancer Institute-designated University of Virginia ... , In this new partnership, OncLive’s editorial and marketing teams will publicize and ...
(Date:5/26/2016)... City, CA (PRWEB) , ... May 26, 2016 , ... ... Silicon Valley-based startup, The Dough Bar, has ignited an undeniable buzz in ... -- a doughnut. But not just any doughnut.  These doughnuts are packed with 11 ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... WASHINGTON , May 26, 2016 ... Microspheres, Associated With Both Cost Savings and ... BTG plc (LSE: BTG), an international specialist healthcare ... data at the 21st Annual Meeting of ISPOR ... that treatment of hepatocellular carcinoma (HCC) using yttrium-90 ...
(Date:5/26/2016)... , May 26, 2016 Since ... matured into an essential life science tool for conducting ... applications. BCC Research reveals in its new report that ... growth phase, one powered by a range of new ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
(Date:5/25/2016)... 25, 2016 According to a ... (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), ... (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021", ... Animation Market for the forecast period of 2016 to ... Million by 2021 from USD 117.3 Million in 2016, ...
Breaking Medicine Technology: